CC BY 4.0 · Rev Bras Ginecol Obstet 2020; 42(12): 851-856
DOI: 10.1055/s-0040-1722522
Febrasgo Position Statement

Vaccination in pregnant and postpartum women

Number 6 - December 2020
1   Universidade Estadual de Campinas, Campinas, SP, Brazil
,
2   Universidade Federal Fluminense, Niterói, RJ, Brazil
,
3   Faculdade de Ciências Médicas de Santos, Santos, SP, Brazil
,
4   Fundação Faculdade Medicina, São Paulo, SP, Brazil
,
5   Faculdade de Medicina do ABC, Santo André, SP, Brazil
› Institutsangaben

Key points

  • Alert gynecologists and obstetricians about the importance of vaccinating pregnant and postpartum women;

  • Address immunological changes in pregnancy and the puerperal period and susceptibility to infections;

  • Highlight the maternal and fetal advantages of vaccination during pregnancy and lactation and offer tools that help obstetricians to convince their patients to adhere to vaccination;

  • Describe the vaccines routinely recommended during pregnancy and puerperal period;

  • Address vaccines given sporadically during pregnancy and puerperal period;

  • Alert about contraindicated vaccines during pregnancy and inform risks of inadvertent use;

  • Address future perspectives on the vaccination of pregnant women.

The National Specialty Commission for Vaccines of the Brazilian Federation of Gynecology and Obstetrics Associations (FEBRASGO) endorses to this document. The content production is based on scientific studies on a thematic proposal and the findings presented contribute to clinical practice.




Publikationsverlauf

Artikel online veröffentlicht:
21. Dezember 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil